Kristen Marie Williams

This profile gathers the share dealings of Kristen Marie Williams in Pacira BioSciences, Inc., where the filings describe the role as senior executive. We count 11 filings; the first trade dates from 4 June 2021 and the latest from 14 June 2023.

The open-market record consists of 3 sales worth €473k, with no purchase. Other entries cover 2 share grants and 6 option exercises. Since January 2023: no purchases and 1 sale on the market.

On 16 June 2023 came the latest disclosure, a share grant in Pacira BioSciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.